Stocks / NASDAQ / BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

Our Opinion

BiondVax Pharmaceuticals Ltd. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical trials of their flu vaccine on animals.


The CSO of BiondVax, Dr Tamar Ben-Yedidia comments, “The universality and immunogenicity of our universal influenza vaccine, M-001, has been demonstrated in animal models and in the clinic. Read full article.

Company Description

BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company. The Company holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, for developing, manufacturing and commercializing the flu vaccine. BiondVax Pharmaceuticals Ltd develops a biopharmaceutical universal flu vaccine, designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. [Source: GoogleFinance]